帕金森患者家庭护理研究进展张凯丽秦子文

首页 -> 往期阅览-> 2025年

《实用全科护理学》( ISSN3080-7638、EISSN3080-7646 )

发布者：Quest Press

发布日期：2025/10/9

10.12479/questpress-syqkhlx.20250135

Open Access

下载2次

浏览83次

帕金森患者家庭护理研究进展

张凯丽秦子文

日照市中医医院，山东日照，276500

摘要：帕金森病（PD）是一种以黑质多巴胺能神经元变性为特征的神经系统退行性疾病，其致病机制尚未完全阐明。当前临床治疗核心仍依赖多巴胺能药物替代疗法，但存在诸多缺陷。随着全球人口老龄化加速，PD 患病率持续上升，其进行性病程导致的躯体功能衰退与家庭照护成本形成双重负担。研究表明，基于循证医学构建的多维度家庭护理干预模式可有效延缓疾病进展并改善患者生存质量。本文系统阐述了涵盖药物精准化管理、抗炎抗氧化饮食护理、阶梯式康复训练、共情心理支持及家居环境安全防护五大核心模块的PD 家庭护理综合框架，旨在为延缓疾病进程、提升患者功能独立性、优化医疗资源配置提供理论依据与实践指导。
关健词：帕金森病；家庭护理；预防管理

Progress in Home Care Research for Parkinson's Disease Patients

Kaili Zhang Ziwen Qin
Rizhao Traditional Chinese Medicine Hospital，Rizhao Shandong 276800，China

Abstract：Parkinson's disease (PD), characterized by substantia nigra dopaminergic neuron degeneration with incompletely defined pathogenesis, relies primarily on dopaminergic pharmacotherapy. Accelerated global aging drives rising PD prevalence, intensifying physical decline and familial care burdens. Evidence-based multidimensional home care effectively slows progression and improves quality of life. This work establishes a comprehensive PD home care framework integrating precision medication management, anti-inflammatory/antioxidant dietary protocols, progressive rehabilitation targeting balance/gait, empathy-driven psychological support, and optimized environmental safety. The framework delivers implementable solutions to delay progression, sustain functional independence, and maximize healthcare resource efficiency.
Keywords : Parkinson's disease;home care;Preventive management

论文收录证明 / 文献检索报告

Document Retrieval Certificate / Proof of Publication Indexing

作者贡献声明 / 贡献确认书

Author Contribution Statement / Certificate of Authorship Contribution

同行评审报告 / 评审意见

Peer Review Report / Peer Review Comments

利益冲突

Conflict of Interest

作者声明不存在任何利益冲突。

The author declares no conflict of interest.

本文采用知识共享“署名 4.0 国际”许可 (CC BY 4.0) 进行许可。许可协议详情请访问： https://creativecommons.org/licenses/by/4.0/。

This article is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). For details of the license, please visit:https://creativecommons.org/licenses/by/4.0/.